Capricor Therapeutics (CAPR) Stock: Buy, Sell, or Hold?
CAPR - Capricor Therapeutics Inc
$8.37
0.07 (0.84%)
â˛
5d:
-9.81%
30d:
+99.76%
90d:
-66.96%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 8, 2026 at $9.02 · last confirmed Sep 8, 2026
Strength: 7.8/10
Get Alerted When CAPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CAPR is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CAPR is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CAPR is currently trading at $8.37, which is considered slightly high relative to its 30-day fair value range of $4.84 to $9.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -5.7) compared to its historical average (133.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CAPR is in a strong downtrend. The price is currently testing key support at $8.18. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAPR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.50 (+240.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CAPR is in a strong downtrend. The price is currently testing key support at $8.18. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAPR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.50 (+240.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.84 -
$9.37
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
Holding CAPR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 240.5% below Wall St target ($28.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.84 -
$9.37
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$8.18
Resistance Level
$11.00
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.66
Wall Street Target
$28.50
(+240.5%)
Revenue Growth (YoY)
-7.9%
PE vs Historical
-5.7 vs 133.6
CHEAP
Share & Embed Analysis
Last updated: September 13, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Karimah Es Sabar
SELL
7529 shares
2026-04-02
Karimah Es Sabar
SELL
53735 shares
2026-04-01
Anthony Bergmann
SELL
25000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$849 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$48 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 59 HOLD |
Advanced CAPR Option Strategies
Professional options setups generated by AI based on today's CAPR price and gamma walls.
